Pyxis Oncology, Inc.PYXSNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank83
3Y CAGR-4.1%
5Y CAGR+54.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-4.1%/yr
Annual compound
5Y CAGR
+54.3%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
8.8x
Strong expansion
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $109.01M | +3.7% |
| 2024 | $105.13M | +27.9% |
| 2023 | $82.20M | -33.4% |
| 2022 | $123.48M | +77.1% |
| 2021 | $69.72M | +460.0% |
| 2020 | $12.45M | +332.4% |
| 2019 | $2.88M | - |